Prostate Cancer UK has criticised the National Institute for Health and Care Excellence (Nice) over its interim decision to reject the use of a hormone therapy for men with the disease.
The charity warned the rejection of apalutamide could leave thousands of men each year without access to a life-extending treatment.
It said this is the second rejection in six months of a new treatment that could help men newly diagnosed with advanced prostate cancer.
According to the charity, the new treatments are particularly important for patients who cannot receive the standard treatment of docetaxel chemotherapy.
This is more likely to affect older men and those with other health conditions and will also affect anyone whose cancer has progressed from localised disease.
Men with advanced prostate cancer set to be denied life-extending drug
telegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraph.co.uk Daily Mail and Mail on Sunday newspapers.
Prostate Cancer UK criticises decision to reject hormone therapy
thetottenhamindependent.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thetottenhamindependent.co.uk Daily Mail and Mail on Sunday newspapers.